Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

Workshop

CLIN

W22--Lungs & Beyond

W22.3- Liver disease outcomes in people with CF after two years of Elexacaftor/Tezacaftor/Ivacaftor – Results from the RECOVER trial

Friday, September 27, 2024
10:15 AM – 12:15 PM ET
Location: 258 A-C

    Speaker(s)

  • Paul McNally

    RCSI University of Medicine and Health Sciences